Article

Daily Medication Pearl: Tavaborole (Kerydin)

Tavaborole (Kerydin) is indicated for the topical treatment of onychomycosis of the toenails.

Medication Pearl of the Day: Tavaborole (Kerydin)

Indication: Tavaborole (Kerydin) is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes.

Insight:

  • Dosing: Apply tavaboroleto affected toenails once daily for 48 weeks.
  • Dosage forms:Solution, 5%.
  • Adverse events: Common adverse reactions occurring in ≥1% in subjects treated with tavaboroleincluded application site exfoliation, ingrown toenail, application site erythema, and application site dermatitis.
  • Mechanism of action: Kerydin is an oxaborole antifungal.
  • Manufacturer: Anacor Pharma

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com